Table: begin end state 1 20 cytoplasmic 21 43 transmembrane 44 49 non-cytoplasmic 50 73 transmembrane 74 84 cytoplasmic 85 103 transmembrane 104 108 non-cytoplasmic 109 130 transmembrane 131 149 cytoplasmic 150 173 transmembrane 174 184 non-cytoplasmic 185 205 transmembrane 206 239 cytoplasmic 240 259 transmembrane 260 279 non-cytoplasmic 280 300 transmembrane 301 306 cytoplasmic 307 326 transmembrane 327 409 non-cytoplasmic 410 434 transmembrane 435 449 cytoplasmic 450 472 transmembrane 473 478 non-cytoplasmic 479 497 transmembrane 498 507 cytoplasmic
Input: >CA265_RS19920 MSDTLPRNNIFKVIGASSLGTLIEWYDFYIFGSLAVIIGHQLFPEDAGASALINTLAIFA AGFIVRPFGALVFGRLGDLIGRKYTFLLTLVLMGGSTFFIGLIPSYKSIGYAAPILVLIL RLIQGLALGGEYGGAATYVAEHAPKNKRGFFTSWIQTTATLGLFLSLGIIVITKNILGAE TFGDWGWRIPFLLSIVLVVVSIYIRMKMHESPMFSKLKAEGNVSKNPLKESFNNKANFKM VLLALFGATMGQGVIWYTGQFYAQSFLENTCKLDFNDSRYILLWGIAFATPFFVIFGAWS DKVGRKWIMLSGMLLGILFYRPIYQIFLDDTDYTKIEQTDILSARPAPVTSVLIANSTDS LRTVSTKVMLKNGASFNKVQTDTVSATKGILLGKEVVKDKILPTPVFWKFVGLIFFQILL VTMVYGPIAAFLVELFPTKIRYTSMSLPYHIGNGVFGGLVPFIATLIASFSGSTPLSGLW YPIGIAALSLVIGAIYLSNKRDENIND
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server